TherapeuticsMD
TXMD
TXMD
43 hedge funds and large institutions have $13.8M invested in TherapeuticsMD in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less call options, than puts
Call options by funds: $2.27M | Put options by funds: $3.4M
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Holders
43
Holding in Top 10
–
Calls
$2.27M
Puts
$3.4M
Top Buyers
| 1 | +$2.42M | |
| 2 | +$551K | |
| 3 | +$268K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$236K |
| 5 |
Millennium Management
New York
|
+$210K |
Top Sellers
| 1 | -$843K | |
| 2 | -$814K | |
| 3 | -$729K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$700K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$537K |